retatrutide weight loss clinical trials results just posted Phase 3 trial showing up to 30% body over 80 weeks. That is approaching bariatric surgery territory, from a medication., It targets three hormone pathways: 📈 RETATRUTIDE PHASE 3 RESULTS:

While generally safe for healthy individuals, certain populationsincluding immunocompromised patients and premature infantsface elevated risks

Include comorbidity documentation in your appeal

What happens if you stop taking the medication Both medications work for as long as you take them

"Will I regain weight after stopping medication?" Evidence suggests weight often returns after stopping GLP-1 treatment, which is why clinician-led maintenance planning and lifestyle support are important

Ressler has a special interest in treating patients with PCOS and increasing awareness of ovarian and breast cancer in the Jewish community through her advocacy work.